[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590208":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":34,"responsibleParty":51,"collaborators":54,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":20,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":20,"enrollmentInfo":66,"targetDuration":20,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":20,"overallStatus":37,"whyStopped":20,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"University Hospital Olomouc","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"patients with extrahepatic cholangiocarcinoma","EXPERIMENTAL","20 patients with known cholangiocarcinoma indicated for endoscopic retrograde cholangiopancreatography over 18 years of age",[13],"Procedure: Endoscopic retrograde cholangiopancreatography (ERCP)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"PROCEDURE","Endoscopic retrograde cholangiopancreatography (ERCP)","Insertion of a endoscopic fiber-optic Raman probe under fluoroscopic control during endoscopic retrograde cholangiopancreatography to measure Raman spectra of extrahepatic cholangiocarcinoma and healthy bile duct.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Peter Slodička, M.D.","PRINCIPAL_INVESTIGATOR",[26,30],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","+420776807612","peter.slodicka@fnol.cz",{"name":31,"role":27,"phone":32,"phoneExt":20,"email":33},"Václav Ranc, Assoc. Prof.","+420732834753","vaclav.ranc@upol.cz",[35],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":20,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Peter Slodička","RECRUITING","Olomouc","Olomouc Region","77900","Czechia",{"type":43,"coordinates":44},"Point",[45,46],17.25175,49.59552,{"lat":46,"lon":45},[49],{"name":36,"role":27,"phone":50,"phoneExt":20,"email":29},"776807612",{"type":24,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Peter Slodicka","Doctor of Medicine, Clinical Doctor, Principal Investigator",[55],{"name":56,"class":6},"Palacky University","100590208","raman-spectroscopy-in-the-diagnosis-of-extrahepatic-cholangiocarcinoma---a-pilot-study-100590208",false,"NCT06964425","Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma - a Pilot Study","Raman Spectroscopy in the Diagnosis of Extrahepatic Cholangiocarcinoma","Inclusion Criteria:\n\n* person older than 18 years, who has known extrahepatic cholangiocarcinoma and is indicated for ERCP\n\nExclusion Criteria:\n\n* disagreement with the study","ALL","18 Years",{"count":67,"type":68},20,"ESTIMATED","INTERVENTIONAL",[71],"NA","Diagnosis of extrahepatic cholangiocarcinoma is challenging because the yield of imaging and tissue sampling is limited. Raman spectroscopy is an optical method based on the analysis of scattered monochromatic light. Raman spectroscopy is able to provide a molecular 'fingerprint' of the tissue to determine its type. The aim of this pilot study was to develop a methodology for in vivo Raman spectroscopy in bile ducts to improve the current diagnostic capabilities of extrahepatic cholangiocarcinoma.",[74,75,76,77,78,79,80,81,82],"Cholangiocarcinoma, Extrahepatic","Cholangiocarcinoma of the Extrahepatic Bile Duct","Cholangiocarcinoma, Perihilar","Diagnosis","Raman Spectroscopy","Klatskin Tumor","Endoscopy","Biliary Stricture","Malignant Biliary Stricture","2025-06-29",{"date":85,"type":86},"2025-07-02","ACTUAL",{"date":88,"type":86},"2023-02-04",{"date":90,"type":68},"2025-07-30",{"name":5,"class":6},1]